• Home
  • Cannabis-Responsive Biomarkers: A Pharmacometabolomics-Based Application to Evaluate the Impact of Medical Cannabis Treatment on Children with Autism Spectrum Disorder.

Cannabis-Responsive Biomarkers: A Pharmacometabolomics-Based Application to Evaluate the Impact of Medical Cannabis Treatment on Children with Autism Spectrum Disorder.

Author List
Siani-Rose M, Cox S, Goldstein B, Abrams D, Taylor M, Kurek I
Publication
Cannabis and cannabinoid research
Publication ID (Profile URL)
https://researcherprofiles.org/profile/255759858
Publication Year
2021
PubMed ID
34874191
Publication Title
Siani-Rose M, Cox S, Goldstein B, Abrams D, Taylor M, Kurek I. Cannabis-Responsive Biomarkers: A Pharmacometabolomics-Based Application to Evaluate the Impact of Medical Cannabis Treatment on Children with Autism Spectrum Disorder. Cannabis Cannabinoid Res. 2023 02; 8(1):126-137.